CI
One fund sold, but the company is still doing the heavy lifting
Robeco Institutional Asset Management B.V. trimmed its Cigna position by 11.2%, selling 10,664 shares and ending the quarter with 84,665 shares worth about $23.3 million. On the surface, that sounds dramatic — like someone quietly leaving the party early.
But here’s the part investors probably care more about: Cigna wasn’t exactly limping into the room. The company just posted $8.08 in EPS, beating estimates of $7.88, on $72.5 billion in revenue. That’s the kind of quarter that makes a single stake reduction feel a lot less like a thesis change and a lot more like routine portfolio housekeeping.
The real headline: guidance, dividend, and the “don’t blink” factor
Cigna also said it expects FY2026 EPS of 30.25, which is a pretty loud way of saying management still sees plenty of runway. Add in a quarterly dividend bump to $1.56, and you’ve got a company trying to check the usual investor boxes: growth, cash returns, and a little confidence on top.
A few extra data points worth keeping in your mental dashboard:
- Analysts still rate the stock a consensus Moderate Buy
- The average price target sits around $333.11
- Institutional investors still own roughly 86.99% of the shares
Big picture
One asset manager trimming a stake is interesting, sure. But when the company is beating, raising, and paying more cash back to shareholders, that’s the stuff that usually moves the needle. In other words: Robeco may have stepped back a little, but Cigna’s own numbers are still doing the heavy lifting.